AnaBios primary human plateable hepatocytes are quality control tested for viability, cell yield post thaw, plating confluency, and CYP enzyme and mRNA induction (NHPH0010).
Sold out
- PRODUCT INFO
- DEMOGRAPHICS
- TESTS
- DOCUMENTATION
Ideal for studies of drug metabolism, toxicity and disease modeling
AnaBios primary human suspension hepatocytes are quality control tested for viability, cell yield post thaw, plating confluency, and CYP enzyme and mRNA induction fold of CYP1A12, CYP2B6, and CYP3A4. Expanded hepatocytes form monolayers of hepatocytes attaching to collagen-coated surfaces for at least up to 5 days. NHPH0010
- Cell Yield: >7 million
- Viability: 90%
- Plateable hepatocytes which remain adherent for 5-14+ days
- Spheroid competency for 3D-based investigations
- Match your research requirements to our biobank of cryopreserved tissues
Donor Demographics:
- Age: 2
- Sex: Male
- Race: Caucasian
- BMI: 17.3
- COD: Anoxia
- Drug Use: No
- Alcohol Use: No
- Smoking Use: No
Standard Tests
| TESTS | RESULTS |
| Donor: HIV, HCV, HBV, RPR | Negative |
| Culture: Gram+, Gram-, Mycoplasm, Fungi | Negative |